| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0009 |